CD56 for Multiple Myeloma: Lack of CD56 May Be Associated with Worse Prognosis.

CD56 for Multiple Myeloma: Lack of CD56 May Be Associated with Worse Prognosis. Acta Haematol. 2018 Aug 15;140(1):40-41 Authors: Miyazaki K, Suzuki K PMID: 30110676 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30110676?dopt=Abstract

Source: Acta Haematologica - August 15, 2018 Category: Hematology Authors: Miyazaki K, Suzuki K Tags: Acta Haematol Source Type: research

More News: Hematology | Myeloma